Search ASX code:
Generic filters

2020: The worst performing shares in the ASX 200

Last year was an extraordinary year. There were some big performances in the ASX 200 (ASX: XJO), but there were also some bad ones. This article is about the three worst performers, and how it happened.

COVID-19 completely smashed some industries, and they remain challenged:

Unibail-Rodamco-Westfield (ASX: URW)

The Unibail-Rodamco-Westfield share price fell by around 54% over the past year.

This business is one of the largest shopping centre real estate investment trusts (REITs) in the world. As the name might suggest, this is the business that bought the international Westfield shopping centres (but not the Australian and New Zealand ones, which are still owned by Scentre Group (ASX: SCG)).

COVID-19 has been particularly economically painful for physical shopping, to the benefit of e-commerce. As a huge landlord, URW is one the ones that are still suffering from changing consumer habits, rental deferments (at best) and a smaller level of foot traffic.

However, URW shares are getting closer to doubling since early November when the vaccine effectiveness news was announced.

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price has fallen by approximately 60% over the last year.

Global travel almost came to a standstill during April as borders shut and governments put in restrictions. As a business that specialises in helping people travel, travel agent business Flight Centre was obviously going to be heavily hit. Things are still nowhere near back to normal for the ASX 200 share. There’s still almost no travel internationally for Aussie passengers, but the domestic market is opening up a bit. Or it was, before the NSW outbreak in December.

Like URW, the Flight Centre share price has gone up a lot since early November thanks to positive vaccine news.

AVITA Medical Inc (ASX: AVH)

The Avita share price has dropped around 62% over the past year.

Avita is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns.

The Avita share price ran hot in 2019 up to February 2020. However, it was (and still is) generating a relatively small amount of revenue compared to its market capitalisation even after such a large decline over 2020. In the first quarter of FY21 it made US$5.1 million of revenue, which was growth of 56% over the prior corresponding period.

Avita is likely to ‘grow into its valuation’ if it keeps growing at that kind of pace, particularly with a gross margin of 82%, but during 2020 the share price may have gotten a bit too hot.

I’m not sure if any of these three bad performers in 2020 can turn things around quickly in 2021, though Avita could keep growing revenue nicely. I think ASX growth shares that are making good profit, like Pushpay Holdings Ltd (ASX: PPH), could continue to be ones to keep an eye on.

Afterpay, Zip Co, Sezzle…

Is BNPL the opportunity of a lifetime or is the sector a ticking time bomb?

Rask's analyst has just finished a 7,500-word report, The Ultimate BNPL Sector Report, taking a deep dive into this booming ASX sector. It shines a spotlight on each of the major players. You can get the full analyst report for FREE by CLICKING HERE NOW or entering your email below.

Note: the report is 100% free.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Afterpay, Zip Co, Sezzle…

Is BNPL the opportunity of a lifetime or is the sector a ticking time bomb?

Rask's analyst has just finished a 7,500-word report, The Ultimate BNPL Sector Report, taking a deep dive into this booming ASX sector. It shines a spotlight on each of the major players. You can get the full analyst report for FREE by CLICKING HERE NOW.

Note: the report is 100% free.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading:

Rask Media’s Ultimate BNPL Sector Report

Afterpay, Zip, Sezzle… is this the opportunity of a lifetime? Or is BNPL a ticking time bomb? This 7,500-word analyst report takes a deep dive into the BNPL sector and shines a spotlight on each of the major players in this booming market. 

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

As we emerge from COVID-19, some tech companies are growing faster than ever. Rask’s investment analysts have identified 3 growth stocks set to benefit. Big time.

Enter your email below to access this report for free, including the names, ticker codes and analysis.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.